Screener
Indivior Pharmaceuticals, Inc. INDV Business Segments — Income Tax
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Indivior Pharmaceuticals, Inc. in its filing.
Tagged under the XBRL concept us-gaap:IncomeTaxExpenseBenefit.
The source filing: Indivior Pharmaceuticals, Inc.’s 10-Q, filed April 30, 2026.
- Filed
- Apr 30, 2026, 4:02 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001628280-26-028850
| Line item | Three Months Ended March 31, 2026 | 2025 |
|---|---|---|
| Interest expense | 7 | 12 |
| Loss on debt extinguishment | 18 | — |
| Income before income taxes | 115 | 59 |
| Income tax expense | 26 | 11 |
| Net income | $89 | $47 |
| *Total SUBLOCADE net revenue | $232 | $176 |
| Depreciation and amortization | $2 | $3 |
| Stock-based compensation expense | $9 | $6 |
Item 1. Unaudited Condensed Financial Statements.
FAQ
- What is Indivior Pharmaceuticals, Inc.'s business segments — income tax?
- Indivior Pharmaceuticals, Inc. (INDV) reported business segments — income tax of $26M in Q1 2026.
- How has Indivior Pharmaceuticals, Inc.'s business segments — income tax changed year-over-year?
- Indivior Pharmaceuticals, Inc.'s business segments — income tax increased by 136.4% year-over-year, from $11M to $26M.
- What is the long-term trend for Indivior Pharmaceuticals, Inc.'s business segments — income tax?
- Over 2 years (2022 to 2024), Indivior Pharmaceuticals, Inc.'s business segments — income tax has grown at a -45.6% compound annual growth rate (CAGR), from -$44M to $13M.
- What does business segments — income tax mean?
- This reflects the total tax liability incurred by the reportable segment based on its taxable income. It is a critical component for understanding the net contribution of the segment to the company's bottom line after regulatory obligations.
Ask your AI about Indivior Pharmaceuticals, Inc.'s business segments — income tax.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude